John-John B. Schnog

erasmus mc

H指数:30

被引数:4,253

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A critical view of the BJH publication on the lack of benefit of second-line daratumumab in patients with functional high-risk multiple myeloma

对BJH关于功能高危多发性骨髓瘤患者二线达雷木单抗缺乏获益的发表的批判性观点

British Journal of Haematology

IF3.8

2026-04-240

PRE

Moving forward from spleen response as an endpoint in randomized controlled trials in myelofibrosis

从骨髓纤维化随机对照试验的脾脏反应终点向前推进

Haematologica

IF7.9

2026-02-010

OAAI

Increasing the focus on critical appraisal of trials and financial conflict of interest in medical training programs: a perspective from oncology

加强医学培训计划中对临床试验的批判性评估和财务利益冲突的关注：来自肿瘤学的视角

Frontiers in Medicine

IF3

2025-10-080

OAAI

Clinical Benefit of Early Daratumumab Use in Multiple Myeloma is Undefined

早期达鲁珠单抗在多发性骨髓瘤中的临床获益尚不明确

American Journal of Hematology

IF9.9

2025-05-290

PRE

Pembrolizumab with chemoradiotherapy followed by pembrolizumab for stage III-IVa cervical cancer: is the ENGOT-cx11/GOG-3047/KEYNOTE-A18 trial practice changing?

Pembrolizumab联合放化疗后联合pembrolizumab治疗III-IVa期宫颈癌: ENGOT-cx11/GOG-3047/KEYNOTE-A18试验实践是否发生变化？

CANCER

IF5.1

2025-02-060

PRE

Untoward global effects of current guideline formulation of stereotactic radiotherapy for symptomatic brain metastases by international medical societies

LANCET REGIONAL HEALTH-AMERICAS

IF7.6

2023-09-011

OAAI

Contemporary oncology trials, drug approvals and the physician-patient relationship

LANCET REGIONAL HEALTH-AMERICAS

IF7.6

2022-07-012

OAAI

An urgent call to raise the bar in oncology

BRITISH JOURNAL OF CANCER

IF6.8

2021-08-1641

OAAI

Sudden death due to massive bone marrow sequestration crisis in a patient with sickle cell disease

AMERICAN JOURNAL OF HEMATOLOGY

IF9.9

2021-01-250

OAAI

N-terminal pro-B-type natriuretic peptide, tricuspid jet flow velocity, and death in adults with sickle cell disease

AMERICAN JOURNAL OF HEMATOLOGY

IF9.9

2015-02-029

OAAI

Nucleosomes and neutrophil activation in sickle cell disease painful crisis

HAEMATOLOGICA

IF7.9

2013-08-0256

OAAI

N-acetylcysteine reduces oxidative stress in sickle cell patients

N-乙酰半胱氨酸降低镰状细胞患者的氧化应激

ANNALS OF HEMATOLOGY

IF2.4

2012-02-1059

OAAI

Oxidative stress in sickle cell disease; pathophysiology and potential implications for disease management

AMERICAN JOURNAL OF HEMATOLOGY

IF9.9

2011-05-04162

PREAI

Urinary markers of bone resorption, pyridinoline and deoxypyridinoline, are increased in sickle cell patients with further increments during painful crisis

AMERICAN JOURNAL OF HEMATOLOGY

IF9.9

2010-09-2916

PREAI

Pain rate and social circumstances rather than cumulative organ damage determine the quality of life in adults with sickle cell disease

AMERICAN JOURNAL OF HEMATOLOGY

IF9.9

2010-06-2336

OAAI

Letter in response to: Pulmonary thrombi are not detected by 3D magnetic resonance angiography in adults with sickle cell anemia and an elevated triscuspid regurgitant jet velocity

AMERICAN JOURNAL OF HEMATOLOGY

IF9.9

2009-12-220

PREAI

Lung function tests in patients with sickle cell disease: A reply

AMERICAN JOURNAL OF HEMATOLOGY

IF9.9

2009-04-080

PREAI

An unusual way of diagnosing sickle-cell disease

AMERICAN JOURNAL OF HEMATOLOGY

IF9.9

2008-10-280

OAAI

Cardiopulmonary imaging, functional and laboratory studies in sickle cell disease associated pulmonary hypertension

AMERICAN JOURNAL OF HEMATOLOGY

IF9.9

2008-09-2517

OAAI

Extremely slow methotrexate elimination in a patient with t(9;22) positive acute lymphoblastic leukemia treated with imatinib

AMERICAN JOURNAL OF HEMATOLOGY

IF9.9

2008-07-098

OAAI

John-John B. Schnog

个人简介

教育背景

工作经历

荣誉奖项

研究方向